224 related articles for article (PubMed ID: 7611277)
1. Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer.
Struewing JP; Brody LC; Erdos MR; Kase RG; Giambarresi TR; Smith SA; Collins FS; Tucker MA
Am J Hum Genet; 1995 Jul; 57(1):1-7. PubMed ID: 7611277
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
[TBL] [Abstract][Full Text] [Related]
3. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.
Johannsson O; Ostermeyer EA; Håkansson S; Friedman LS; Johansson U; Sellberg G; Brøndum-Nielsen K; Sele V; Olsson H; King MC; Borg A
Am J Hum Genet; 1996 Mar; 58(3):441-50. PubMed ID: 8644702
[TBL] [Abstract][Full Text] [Related]
4. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families.
Ikeda N; Miyoshi Y; Yoneda K; Shiba E; Sekihara Y; Kinoshita M; Noguchi S
Int J Cancer; 2001 Jan; 91(1):83-8. PubMed ID: 11149425
[TBL] [Abstract][Full Text] [Related]
5. A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families.
Serova O; Montagna M; Torchard D; Narod SA; Tonin P; Sylla B; Lynch HT; Feunteun J; Lenoir GM
Am J Hum Genet; 1996 Jan; 58(1):42-51. PubMed ID: 8554067
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations.
Couch FJ; Garber J; Kiousis S; Calzone K; Hauser ER; Merajver SD; Frank TS; Boehnke M; Chamberlain JS; Collins FS
J Natl Cancer Inst Monogr; 1995; (17):9-14. PubMed ID: 8573462
[TBL] [Abstract][Full Text] [Related]
7. Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds.
Berman DB; Wagner-Costalas J; Schultz DC; Lynch HT; Daly M; Godwin AK
Am J Hum Genet; 1996 Jun; 58(6):1166-76. PubMed ID: 8651293
[TBL] [Abstract][Full Text] [Related]
8. German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene.
Hamann U; Brauch H; Garvin AM; Bastert G; Scott RJ
Genes Chromosomes Cancer; 1997 Feb; 18(2):126-32. PubMed ID: 9115962
[TBL] [Abstract][Full Text] [Related]
9. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
Ticha I; Kleibl Z; Stribrna J; Kotlas J; Zimovjanova M; Mateju M; Zikan M; Pohlreich P
Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348
[TBL] [Abstract][Full Text] [Related]
10. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families.
Simard J; Tonin P; Durocher F; Morgan K; Rommens J; Gingras S; Samson C; Leblanc JF; Bélanger C; Dion F
Nat Genet; 1994 Dec; 8(4):392-8. PubMed ID: 7894492
[TBL] [Abstract][Full Text] [Related]
11. Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes.
Chang-Claude J; Dong J; Schmidt S; Shayeghi M; Komitowski D; Becher H; Stratton MR; Royer-Pokora B
J Med Genet; 1998 Feb; 35(2):116-21. PubMed ID: 9507390
[TBL] [Abstract][Full Text] [Related]
12. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.
Unger MA; Nathanson KL; Calzone K; Antin-Ozerkis D; Shih HA; Martin AM; Lenoir GM; Mazoyer S; Weber BL
Am J Hum Genet; 2000 Oct; 67(4):841-50. PubMed ID: 10978226
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing.
De Leeneer K; Coene I; Crombez B; Simkens J; Van den Broecke R; Bols A; Stragier B; Vanhoutte I; De Paepe A; Poppe B; Claes K
Breast Cancer Res Treat; 2012 Feb; 132(1):87-95. PubMed ID: 21553119
[TBL] [Abstract][Full Text] [Related]
14. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
Byrski T
Ann Acad Med Stetin; 2003; 49():27-43. PubMed ID: 15552838
[TBL] [Abstract][Full Text] [Related]
15. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
16. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
[TBL] [Abstract][Full Text] [Related]
17. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families.
Friedman LS; Szabo CI; Ostermeyer EA; Dowd P; Butler L; Park T; Lee MK; Goode EL; Rowell SE; King MC
Am J Hum Genet; 1995 Dec; 57(6):1284-97. PubMed ID: 8533757
[TBL] [Abstract][Full Text] [Related]
18. Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer.
Cornelis RS; Vasen HF; Meijers-Heijboer H; Ford D; van Vliet M; van Tilborg AA; Cleton FJ; Klijn JG; Menko FH; Meera Khan P
Hum Genet; 1995 May; 95(5):539-44. PubMed ID: 7759075
[TBL] [Abstract][Full Text] [Related]
19. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.
Górski B; Byrski T; Huzarski T; Jakubowska A; Menkiszak J; Gronwald J; Pluzańska A; Bebenek M; Fischer-Maliszewska L; Grzybowska E; Narod SA; Lubiński J
Am J Hum Genet; 2000 Jun; 66(6):1963-8. PubMed ID: 10788334
[TBL] [Abstract][Full Text] [Related]
20. Low incidence of BRCA1 mutations among Italian families with breast and ovarian cancer.
Santarosa M; Viel A; Dolcetti R; Crivellari D; Magri MD; Pizzichetta MA; Tibiletti MG; Gallo A; Tumolo S; Del Tin L; Boiocchi M
Int J Cancer; 1998 Nov; 78(5):581-6. PubMed ID: 9808526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
